Phosphorylation and calcium antagonistically tune myosin-binding protein C’s structure and function

During each heartbeat, cardiac contractility results from calcium-activated sliding of actin thin filaments toward the centers of myosin thick filaments to shorten cellular length. Cardiac myosin-binding protein C (cMyBP-C) is a component of the thick filament that appears to tune these mechanochemi...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 113; no. 12; pp. 3239 - 3244
Main Authors: Previs, Michael J., Mun, Ji Young, Michalek, Arthur J., Previs, Samantha Beck, Gulick, James, Robbins, Jeffrey, Warshaw, David M., Craig, Roger
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 22-03-2016
National Acad Sciences
Series:From the Cover
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During each heartbeat, cardiac contractility results from calcium-activated sliding of actin thin filaments toward the centers of myosin thick filaments to shorten cellular length. Cardiac myosin-binding protein C (cMyBP-C) is a component of the thick filament that appears to tune these mechanochemical interactions by its N-terminal domains transiently interacting with actin and/or the myosin S2 domain, sensitizing thin filaments to calcium and governing maximal sliding velocity. Both functional mechanisms are potentially further tunable by phosphorylation of an intrinsically disordered, extensible region of cMyBP-C’s N terminus, the M-domain. Using atomic force spectroscopy, electron microscopy, and mutant protein expression, we demonstrate that phosphorylation reduced the M-domain’s extensibility and shifted the conformation of the N-terminal domain from an extended structure to a compact configuration. In combination with motility assay data, these structural effects of M-domain phosphorylation suggest a mechanism for diminishing the functional potency of individual cMyBP-C molecules. Interestingly, we found that calcium levels necessary to maximally activate the thin filament mitigated the structural effects of phosphorylation by increasing M-domain extensibility and shifting the phosphorylated N-terminal fragments back to the extended state, as if unphosphorylated. Functionally, the addition of calcium to the motility assays ablated the impact of phosphorylation on maximal sliding velocities, fully restoring cMyBP-C’s inhibitory capacity. We conclude that M-domain phosphorylation may have its greatest effect on tuning cMyBP-C’s calcium-sensitization of thin filaments at the low calcium levels between contractions. Importantly, calcium levels at the peak of contraction would allow cMyBP-C to remain a potent contractile modulator, regardless of cMyBP-C’s phosphorylation state.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
2Present address: Department of Biomedical Laboratory Science, College of Health Science, Eulji University, Seongnam-Si, Gyeonggi-Do 13135, Republic of Korea.
1M.J.P., J.Y.M., and A.J.M. contributed equally to this work.
Author contributions: M.J.P., J.Y.M., A.J.M., D.M.W., and R.C. designed research; M.J.P., J.Y.M., A.J.M., and S.B.P. performed research; J.G. and J.R. contributed new reagents/analytic tools; M.J.P., J.Y.M., A.J.M., and S.B.P. analyzed data; and M.J.P., J.Y.M., A.J.M., D.M.W., and R.C. wrote the paper.
Edited by James A. Spudich, Stanford University School of Medicine, Stanford, CA, and approved January 21, 2016 (received for review November 10, 2015)
3Present address: Department of Mechanical and Aeronautical Engineering, Clarkson University, Potsdam, NY 13699.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1522236113